300 related articles for article (PubMed ID: 27428431)
1. Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals.
Serrano-Villar S; Rojo D; Martínez-Martínez M; Deusch S; Vázquez-Castellanos JF; Bargiela R; Sainz T; Vera M; Moreno S; Estrada V; Gosalbes MJ; Latorre A; Seifert J; Barbas C; Moya A; Ferrer M
EBioMedicine; 2016 Jun; 8():203-216. PubMed ID: 27428431
[TBL] [Abstract][Full Text] [Related]
2. How can the gut microbiota affect immune recovery in HIV-infected individuals?
Serrano-Villar S; Ferrer M; Gosalbes MJ; Moreno S
Future Microbiol; 2017 Mar; 12():195-199. PubMed ID: 28262047
[No Abstract] [Full Text] [Related]
3. Enrichment of gut-derived Fusobacterium is associated with suboptimal immune recovery in HIV-infected individuals.
Lee SC; Chua LL; Yap SH; Khang TF; Leng CY; Raja Azwa RI; Lewin SR; Kamarulzaman A; Woo YL; Lim YAL; Loke P; Rajasuriar R
Sci Rep; 2018 Sep; 8(1):14277. PubMed ID: 30250162
[TBL] [Abstract][Full Text] [Related]
4. Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals.
Xie Y; Sun J; Wei L; Jiang H; Hu C; Yang J; Huang Y; Ruan B; Zhu B
BMC Microbiol; 2021 Jan; 21(1):11. PubMed ID: 33407128
[TBL] [Abstract][Full Text] [Related]
5. Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy.
Russo E; Nannini G; Sterrantino G; Kiros ST; Di Pilato V; Coppi M; Baldi S; Niccolai E; Ricci F; Ramazzotti M; Pallecchi M; Lagi F; Rossolini GM; Bartoloni A; Bartolucci G; Amedei A
World J Gastroenterol; 2022 Feb; 28(6):635-652. PubMed ID: 35317423
[TBL] [Abstract][Full Text] [Related]
6. Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals.
Vázquez-Castellanos JF; Serrano-Villar S; Latorre A; Artacho A; Ferrús ML; Madrid N; Vallejo A; Sainz T; Martínez-Botas J; Ferrando-Martínez S; Vera M; Dronda F; Leal M; Del Romero J; Moreno S; Estrada V; Gosalbes MJ; Moya A
Mucosal Immunol; 2015 Jul; 8(4):760-72. PubMed ID: 25407519
[TBL] [Abstract][Full Text] [Related]
7. Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials.
Kim CJ; Walmsley SL; Raboud JM; Kovacs C; Coburn B; Rousseau R; Reinhard R; Rosenes R; Kaul R
HIV Clin Trials; 2016 Jul; 17(4):147-57. PubMed ID: 27267710
[TBL] [Abstract][Full Text] [Related]
8. The accumulation of plasma acylcarnitines are associated with poor immune recovery in HIV-infected individuals.
Qian S; Chen X; Wu T; Sun Y; Li X; Fu Y; Zhang Z; Xu J; Han X; Ding H; Jiang Y
BMC Infect Dis; 2021 Aug; 21(1):808. PubMed ID: 34384363
[TBL] [Abstract][Full Text] [Related]
9. Microbiome of HIV-infected people.
Dubourg G; Surenaud M; Lévy Y; Hüe S; Raoult D
Microb Pathog; 2017 May; 106():85-93. PubMed ID: 27216237
[TBL] [Abstract][Full Text] [Related]
10. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
[TBL] [Abstract][Full Text] [Related]
11. Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy.
Li SX; Armstrong A; Neff CP; Shaffer M; Lozupone CA; Palmer BE
Clin Pharmacol Ther; 2016 Jun; 99(6):600-11. PubMed ID: 26940481
[TBL] [Abstract][Full Text] [Related]
12. Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically suppressive combination antiretroviral therapy.
Tincati C; Merlini E; Braidotti P; Ancona G; Savi F; Tosi D; Borghi E; Callegari ML; Mangiavillano B; Barassi A; Bulfamante G; d'Arminio Monforte A; Romagnoli S; Chomont N; Marchetti G
AIDS; 2016 Apr; 30(7):991-1003. PubMed ID: 27028142
[TBL] [Abstract][Full Text] [Related]
13. Altered gut microbiome composition in HIV infection: causes, effects and potential intervention.
Bandera A; De Benedetto I; Bozzi G; Gori A
Curr Opin HIV AIDS; 2018 Jan; 13(1):73-80. PubMed ID: 29045252
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota diversity predicts immune status in HIV-1 infection.
Nowak P; Troseid M; Avershina E; Barqasho B; Neogi U; Holm K; Hov JR; Noyan K; Vesterbacka J; Svärd J; Rudi K; Sönnerborg A
AIDS; 2015 Nov; 29(18):2409-18. PubMed ID: 26355675
[TBL] [Abstract][Full Text] [Related]
15. Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.
Annavajhala MK; Khan SD; Sullivan SB; Shah J; Pass L; Kister K; Kunen H; Chiang V; Monnot GC; Ricupero CL; Mazur RA; Gordon P; de Jong A; Wadhwa S; Yin MT; Demmer RT; Uhlemann AC
mSphere; 2020 Feb; 5(1):. PubMed ID: 32024712
[TBL] [Abstract][Full Text] [Related]
16. The CD4 slope can be a predictor of immunologic recovery in advanced HIV patients: a case-control study.
Kim KH; Yi J; Lee SH
Korean J Intern Med; 2015 Sep; 30(5):705-13. PubMed ID: 26354065
[TBL] [Abstract][Full Text] [Related]
17. HIV infection results in metabolic alterations in the gut microbiota different from those induced by other diseases.
Serrano-Villar S; Rojo D; Martínez-Martínez M; Deusch S; Vázquez-Castellanos JF; Sainz T; Vera M; Moreno S; Estrada V; Gosalbes MJ; Latorre A; Margolles A; Seifert J; Barbas C; Moya A; Ferrer M
Sci Rep; 2016 May; 6():26192. PubMed ID: 27189771
[TBL] [Abstract][Full Text] [Related]
18. Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers.
Vesterbacka J; Rivera J; Noyan K; Parera M; Neogi U; Calle M; Paredes R; Sönnerborg A; Noguera-Julian M; Nowak P
Sci Rep; 2017 Jul; 7(1):6269. PubMed ID: 28740260
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota Diversity in HIV-Infected Patients on Successful Antiretroviral Treatment is Linked to Sexual Preferences but not CD4 Nadir.
Jabłonowska E; Strzelczyk J; Piekarska A; Wójcik-Cichy K
Arch Immunol Ther Exp (Warsz); 2021 May; 69(1):14. PubMed ID: 33983543
[TBL] [Abstract][Full Text] [Related]
20. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
